查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1766352

远距病人监护设备市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

Remote Patient Monitoring Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 135 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024年，全球远距病人监护设备市场规模达170亿美元，预计到2034年将以13.5%的复合年增长率成长，达到575亿美元。这一快速增长主要得益于糖尿病、心血管疾病和慢性肾臟病等慢性疾病的日益流行。政府支持数位医疗的倡议以及远距病人监护设备的广泛应用，正在推动市场扩张。这些设备提供即时健康资料收集，从而能够及早发现健康异常并及时干预，改善患者的预后。远距病人监护设备种类繁多，从穿戴式感测器到手持式仪器，可追踪各种健康指标，包括心率、血糖和血压。

远端病人监控设备市场 - IMG1

这些设备透过无线方式将资料传输给医疗专业人员，从而实现持续的健康监测，增强患者参与度，并支援基于价值的医疗保健模式。此外，穿戴式技术、感测器精度和人工智慧整合方面的进步，即使在发展中国家也正在提高监测解决方案的效率和客製化程度。随着医疗保健系统借助数位化工具不断发展，远距医疗市场也受益于技术进步和远距照护需求的不断增长，持续成长。

市场范围
起始年份 2024
预测年份 2025-2034
起始值 170亿美元
预测值 575亿美元
复合年增长率 13.5%

2024年，心臟监测市场规模达40亿美元，预计2034年将以13.8%的复合年增长率成长。技术进步推动了对心臟监测设备日益增长的需求，这些设备的精度和可靠性也得到了提升。这些设备能够持续监测心率、心律和其他心臟指标等重要指标，以便在必要时快速介入。

2024 年，糖尿病领域占了相当大的市场份额，达到 22.7%。持续监测血糖水平和胰岛素管理等关键健康参数对于糖尿病护理至关重要，而 RPM 设备有助于即时追踪、早期发现併发症并及时干预，从而防止严重后果和住院。

2024年，美国远距病人监护设备市场规模达63亿美元。高血压和心血管疾病等需要持续监测的慢性疾病的盛行率不断上升，推动了美国远距病人监护设备市场的扩张。智慧血压监测仪和脉搏血氧仪等远距监护解决方案使患者和医疗保健提供者能够即时追踪这些病情，从而促进了市场的成长。

远距病人监护设备产业的主要参与者包括强生、西门子医疗、美敦力、欧姆龙、VitalConnect、雅培实验室、罗氏製药等。这些公司透过提供先进的远距监护解决方案来增强病人护理并改善临床疗效，在塑造行业方面发挥重要作用。为了巩固其在远距病人监护设备市场的地位，各公司正专注于多种策略。他们正大力投资于创新技术的研发，例如人工智慧驱动的监护系统和改进的可穿戴设备。与医疗服务提供者、医院和远距医疗平台建立策略合作伙伴关係正在扩大他们的影响力。各公司也致力于透过提供适合不同区域医疗需求的产品来扩大其全球影响力。此外，许多参与者正在将远距医疗服务与远距病人监护设备相结合，以提供更全面的护理。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

  • 产业生态系统分析
    • 供应商格局
    • 影响价值链的因素
  • 产业衝击力
    • 成长动力
      • 全球慢性病发生率上升
      • 新兴国家可支配收入和医疗保健支出不断增长
      • 已开发国家的技术进步
      • 远距病人监护设备的普及率不断提高
    • 产业陷阱与挑战
      • 设备成本高
      • 严格的监管框架
    • 市场机会
      • 人工智慧预测监控工具的采用率不断提高
      • 穿戴式生物感测器的出现，用于持续、即时的健康追踪
  • 成长潜力分析
  • 监管格局
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 技术和创新格局
    • 当前的技术趋势
    • 新兴技术
  • 未来市场趋势
  • 专利分析
  • 差距分析
  • 波特的分析
  • PESTEL分析

第四章：竞争格局

  • 介绍
  • 公司市占率分析
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 策略仪表板
  • 关键进展
    • 併购
    • 伙伴关係与合作
    • 新产品发布
    • 扩张计划

第五章：市场估计与预测：按产品，2021 - 2034 年

  • 主要趋势
  • 心臟监测设备
  • 血压监测设备
  • 神经监测设备
  • 呼吸监测设备
  • 多参数监测设备
  • 血糖监测设备
  • 胎儿及新生儿监护设备
  • 睡眠监测设备
  • 其他产品

第六章：市场估计与预测：按应用，2021 - 2034 年

  • 主要趋势
  • 心血管疾病
  • 癌症
  • 糖尿病
  • 神经系统疾病
  • 传染病
  • 呼吸系统疾病
  • 其他应用

第七章：市场估计与预测：依最终用途，2021 - 2034 年

  • 主要趋势
  • 居家照护环境
  • 长期照护
  • 其他最终用途

第八章：市场估计与预测：按地区，2021 - 2034 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 俄罗斯
    • 波兰
    • 瑞士
    • 荷兰
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 泰国
    • 印尼
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 智利
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 以色列

第九章：公司简介

  • Abbott Laboratories
  • Baxter International
  • Boston Scientific
  • Cerner
  • DexCom
  • F. Hoffmann-La Roche
  • General Electric Company
  • Johnson & Johnson
  • Koninklijke Philips
  • Medtronic
  • OMRON
  • Siemens Healthineers
  • VitalConnect
简介目录
Product Code: 5563

The Global Remote Patient Monitoring Devices Market was valued at USD 17 billion in 2024 and is estimated to grow at a CAGR of 13.5% to reach USD 57.5 billion by 2034. This rapid growth is largely driven by the increasing prevalence of chronic diseases such as diabetes, cardiovascular conditions, and chronic kidney disease. Government initiatives supporting digital health and the widespread adoption of RPM devices are fueling the market expansion. These devices offer real-time health data collection, which enables early detection of health irregularities and timely interventions, improving patient outcomes. RPM devices, which range from wearable sensors to handheld instruments, track various health metrics, including heart rate, blood glucose, and blood pressure.

Remote Patient Monitoring Devices Market - IMG1

These devices transmit data wirelessly to healthcare professionals, allowing continuous health monitoring, enhancing patient engagement, and supporting value-based healthcare models. Furthermore, advancements in wearable technologies, sensor accuracy, and AI integration are improving the efficiency and customization of monitoring solutions, even in developing nations. As healthcare systems evolve with digital tools, the RPM market continues to grow, benefiting from technological advancements and increasing demand for remote care.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$17 Billion
Forecast Value$57.5 Billion
CAGR13.5%

The cardiac monitoring segment generated USD 4 billion in 2024 and is expected to grow at a CAGR of 13.8% through 2034. The rising demand for cardiac monitoring devices is driven by advancements in technology, which have improved the precision and reliability of these tools. These devices allow continuous monitoring of vital metrics such as heart rate, rhythm, and other cardiac indicators, enabling rapid intervention when necessary.

The diabetes segment held a significant share of the market at 22.7% in 2024. Continuous monitoring of key health parameters, such as blood glucose levels and insulin management, is essential for diabetes care, and RPM devices facilitate real-time tracking, early detection of complications, and timely intervention, thereby preventing severe outcomes and hospitalizations.

U.S. Remote Patient Monitoring Devices Market was valued at USD 6.3 billion in 2024 The country's expansion in this sector is fueled by the rising prevalence of chronic diseases, such as hypertension and cardiovascular conditions, which require continuous monitoring. Remote monitoring solutions like smart blood pressure monitors and pulse oximeters are enabling patients and healthcare providers to track these conditions in real-time, contributing to market growth.

The key players in the Remote Patient Monitoring Devices Industry include Johnson & Johnson, Siemens Healthineers, Medtronic, OMRON, VitalConnect, Abbott Laboratories, F. Hoffmann-La Roche, and others. These companies are instrumental in shaping the industry by providing advanced remote monitoring solutions that enhance patient care and improve clinical outcomes. To strengthen their position in the RPM devices market, companies are focusing on multiple strategies. They are heavily investing in the research and development of innovative technologies such as AI-driven monitoring systems and improved wearable devices. Strategic partnerships with healthcare providers, hospitals, and telemedicine platforms are enhancing their reach. Companies are also focusing on expanding their global presence by offering products suited to different regional healthcare needs. Additionally, many players are integrating telehealth services with RPM devices to deliver more comprehensive care.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/Country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional
    • 2.2.2 Product
    • 2.2.3 Application
    • 2.2.4 End use
  • 2.3 CXO perspectives: Strategic imperatives
    • 2.3.1 Key decision points for industry executives
    • 2.3.2 Critical success factors for market players
  • 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Supplier landscape
    • 3.1.2 Factor affecting the value chain
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising incidence of chronic diseases across the globe
      • 3.2.1.2 Growing disposable income and healthcare expenditure in emerging countries
      • 3.2.1.3 Technological advancement in developed nations
      • 3.2.1.4 Growing adoption of remote patient monitoring devices
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost of devices
      • 3.2.2.2 Stringent regulatory framework
    • 3.2.3 Market opportunities
      • 3.2.3.1 Increasing adoption of AI-powered predictive monitoring tools
      • 3.2.3.2 Emergence of wearable biosensors for continuous, real-time health tracking
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
    • 3.4.4 Latin America
    • 3.4.5 Middle East & Africa
  • 3.5 Technology and innovation landscape
    • 3.5.1 Current technological trends
    • 3.5.2 Emerging technologies
  • 3.6 Future market trends
  • 3.7 Patent analysis
  • 3.8 Gap analysis
  • 3.9 Porter's analysis
  • 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard
  • 4.7 Key developments
    • 4.7.1 Mergers & acquisitions
    • 4.7.2 Partnerships & collaborations
    • 4.7.3 New product launches
    • 4.7.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Cardiac monitoring devices
  • 5.3 Blood pressure monitoring devices
  • 5.4 Neurological monitoring devices
  • 5.5 Respiratory monitoring devices
  • 5.6 Multiparameter monitoring devices
  • 5.7 Blood glucose monitoring devices
  • 5.8 Fetal and neonatal monitoring devices
  • 5.9 Sleep monitoring devices
  • 5.10 Other products

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Cardiovascular diseases
  • 6.3 Cancer
  • 6.4 Diabetes
  • 6.5 Neurological disorders
  • 6.6 Infectious diseases
  • 6.7 Respiratory diseases
  • 6.8 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Home-care settings
  • 7.3 Long-term care
  • 7.4 Other end use

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Russia
    • 8.3.7 Poland
    • 8.3.8 Switzerland
    • 8.3.9 Netherlands
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Thailand
    • 8.4.7 Indonesia
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Colombia
    • 8.5.5 Chile
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE
    • 8.6.4 Israel

Chapter 9 Company Profiles

  • 9.1 Abbott Laboratories
  • 9.2 Baxter International
  • 9.3 Boston Scientific
  • 9.4 Cerner
  • 9.5 DexCom
  • 9.6 F. Hoffmann-La Roche
  • 9.7 General Electric Company
  • 9.8 Johnson & Johnson
  • 9.9 Koninklijke Philips
  • 9.10 Medtronic
  • 9.11 OMRON
  • 9.12 Siemens Healthineers
  • 9.13 VitalConnect